Week In Review This week’s harvest tilts heavily toward a single mechanistic story told from many angles: aging tissues lose the capacity to manage their own waste, and clearing or modulating that waste — proteins, RNA, damaged organelles, senescent cells — produces large functional gains in old animals. The signature paper
Week In Review This week’s intelligence-augmentation news clustered around a single argument: the platforms that mediate everyday cognitive work are being rebuilt around AI agents, and the companies setting the terms are racing to lock in distribution before the next product cycle. On the consumer side, Google races to
Week In Review The dominant story of the week was the industrialization of agentic AI. The era of demos and pilots gave way to formal deployment vehicles: OpenAI stood up a $4 billion services arm to put forward-deployed engineers inside Fortune 500 customers (OpenAI launches the OpenAI Deployment Company), Anthropic
Week In Review This week marked an inflection point in how robotics is talked about: less “can it work” and more “for how long, at what cost, and at what scale”. The week’s most-discussed clip was a Figure AI humanoid running for 50 hours without intervention on a package-sorting
Week In Review This week the headlines were dominated by what big telescopes can now do at the extremes of distance and detail. The James Webb Space Telescope, drawing on the COSMOS-Web survey, produced the clearest map ever made of the cosmic web, tracing the dark-matter scaffolding back to when
Week In Review The dominant story of the week was the public-market debut of next-generation geothermal: Fervo Energy’s IPO priced at the top of its range and popped 33% on its first day of trading, pushing its market valuation past $10 billion and validating enhanced geothermal systems as a
AI
Executive Summary This week's signal is that the AI stack is being repriced simultaneously at every layer, from silicon to capital structure. Cerebras prices its IPO today at a $48.8B valuation, twenty-times oversubscribed, while Anthropic is in advanced talks to raise $30-50B at a $850-950B pre-money valuation
Week In Review This week’s longevity literature was unusually rich in comparative biology — the field that asks why some animals barely age and what their tricks might teach us. A new Aging Cell paper on the Greenland shark catalogues centuries of cardiac wear in a species that nonetheless keeps
Resource Abundance
Executive Summary This week's selection cuts across the entire material-abundance stack, from the atom up to the orbital. The dominant signal is that generative AI is now embedded operationally in two domains that have historically been bottlenecks for material throughput: inorganic materials synthesis (MIT's DiffSyn for
Week In Review The week’s strongest theme is measurement. Three independent groups all moved aging clocks closer to clinical utility: a major Cell paper from China’s Aging Biomarker Consortium introduced “Multimodal Clocks of Human Aging” and a “Digital Aging Twin” framework that tracks individual organs aging at different
Energy
Executive Summary The week of May 5 - May 12, 2026 was unusually fusion-heavy, but with a substantive twist: the headlines were not net-energy claims, they were the enabling infrastructure that determines whether the next generation of fusion machines actually reaches the grid. Helion unveiled "Tiny Merge," a
Longevity
Executive Summary The week of May 4 - May 11, 2026 was anchored by a single clinical readout that the geroscience field had been waiting on for months: BioAge Labs' Phase 1 data for the oral NLRP3 inhibitor BGE-102, showing a median 86% reduction in high-sensitivity C-reactive protein at